FDA CBD Roundup

On May 31, 2019, the U.S. Food and Drug Administration (“FDA”) held a much-anticipated public hearing regarding “Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.” Since that time, FDA has reiterated its existing regulatory and enforcement approach to products containing cannabidiol (“CBD”) while also evaluating other science-based policy approaches for CBD products.…

CBD vs. Opioid Addiction

CBD is everywhere, with multiple claims that it can potentially treat everything from anxiety to cancer. However, scientific evidence is still in its infancy phase for this wonder compound. CBD, also known as cannabidiol has shown beneficial promise for some health-related ailments during animal studies. But it wasn’t until the FDA approved the first cannabis-based…

CBD Regulations in Professional Sports

At the start of 2018, the removal of cannabidiol (CBD) from the World Anti-Doping Agency’s (WADA) banned substances list went into effect. This change prompted an inquiry about the rules regarding CBD in other sports organizations, especially in the United States. While many focus on the topic of marijuana in sports, we were curious as to how sports organizations handle CBD, if at all. CBD, or…